Abstract

The emergence of severe acute respiratory syndrome 2 (SARS-CoV-2) has led the medical and scientific community to address questions surrounding the pathogenesis and clinical presentation of COVID-19; however, relevant clinical models outside of humans are still lacking. In felines, a ubiquitous coronavirus, described as feline coronavirus (FCoV), can present as feline infectious peritonitis (FIP)—a leading cause of mortality in young cats that is characterized as a severe, systemic inflammation. The diverse extrapulmonary signs of FIP and rapidly progressive disease course, coupled with a closely related etiologic agent, present a degree of overlap with COVID-19. This paper will explore the molecular and clinical relationships between FIP and COVID-19. While key differences between the two syndromes exist, these similarities support further examination of feline coronaviruses as a naturally occurring clinical model for coronavirus disease in humans.

Highlights

  • Relationships between COVID-19In the 1960s, feline infectious peritonitis (FIP) was described as a disease in domestic cats and later recognized to be of a viral etiology, feline coronavirus (FCoV) [1,2].In a majority of cats, infection with FCoV results in mild to inapparent clinical signs; a small subset will develop severe illness and succumb to the systemic form of the disease, known as FIP [3]

  • The widespread transmission of FCoV/SARSCoV-2 and the insidious onset of severe signs for both FIP and COVID-19 limits the ability for early disease detection—what may begin as only mild or even inapparent clinical signs or symptoms can rapidly lead to systemic disease [3,4]

  • In the it has been suggested that extrapulmonary signs are due to viral-mediated endotheliitis, sections, we describe these extrapulmonary signs and point out key similarities and leading to vasculitis, primarily in veins with little arteriolar involvement [48,49]

Read more

Summary

Introduction

In the 1960s, feline infectious peritonitis (FIP) was described as a disease in domestic cats and later recognized to be of a viral etiology, feline coronavirus (FCoV) [1,2]. In a majority of cats, infection with FCoV results in mild to inapparent clinical signs; a small subset will develop severe illness and succumb to the systemic form of the disease, known as FIP [3]. The widespread transmission of FCoV/SARSCoV-2 and the insidious onset of severe signs for both FIP and COVID-19 limits the ability for early disease detection—what may begin as only mild or even inapparent clinical signs or symptoms can rapidly lead to systemic disease [3,4]. We believe that FIP may represent a valuable, naturally occurring extrapulmonary model of COVID-19. Both FCoV and SARS-CoV-2 belong to the family Coronaviridae [4,5], albeit in distinct genera (Figure 1). FCoV along with similar animal coronaviruses, such as canine coronavirus (CCoV) and transmissible gastroenteritis virus (TGEV) in pigs, belong to the genus alphacoronavirus.

Phylogenetic
FCoV accounts the vast majority
Transmission
General Clinical
Biomarkers
Neurological
Ophthalmological
Cardiovascular
Gastroenterological
Dermatology
Theriogenological
Immunologic Response
Molecular Similarities between the FCoV and SARS-CoV-2 Spike Proteins
Prevention and Treatment
Clinical Care and Therapeutic Options
MIS-C and PASC
Findings
10. SARS-CoV-2 Infection of Cats
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.